SBIR/STTR Research Award

IMMUNOASSAYS FOR MUTAGENIC AND CARCINOGENIC ADDUCTS IN HUMAN DNA

Award identifier b5bd995fa714e74422defa68b78cb5ce03e50126dcf1163263991eafb14b5adfAwarding agency Department of Health and Human Services

Award amount

$432,000

Program and phase

SBIR · Phase II

Award year

1989

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Proteins International Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DIFUNCTIONAL CARBONYL COMPOUNDS ARE TOXIC, MUTAGENIC, AND CARCINOGENIC AND ARE UBIQUITOUS CONTAMINANTS OF THE HUMAN ENVIRONMENT. THE SIMPLEST EXAMPLES OF SUCH COMPOUNDS ARE MALONDIALDEHYDE, ACROLEIN, AND METHYL GLYOXAL. MALONDIALDEHYDE IS A PRODUCT OF LIPID PEROXIDATION AND PROSTAGLANDIN BIOSYNTHESIS AND IS PRESENT IN VIRTUALLY ALL MAMMALIAN TISSUES. METHYL GLYOXAL IS ALSO A NATURAL PRODUCTAND IS PRESENT IN FRESHLY ROASTED COFFEE. ACROLEIN IS A MAJOR INDUSTRIAL STARTING MATERIAL AND IS PRESENT IN CIGARETTE SMOKE. ALL OF THESE COMPOUNDS ARE MUTAGENIC, AND METHYL GLYOXAL INDUCES SUBCUTANEOUS TUMORS WHEN INJECTED IN MICE. THE EXTENT TO WHICH DIFUNCTIONAL CARBONYL COMPOUNDS CONTRIBUTE TO HUMAN CANCER IS UNCERTAIN, BUT THERE CAN BE LITTLE DOUBT THAT EXPOSURE TO THESE COMPOUNDS IS CONSIDERABLE. WHILE IT IS THOUGHT THAT THESE COMPOUNDS EXERT THEIR MUTAGENIC AND CARCINOGENIC EFFECTS BY FORMING ADDUCTS WITH DNA, METHODS FOR ACCURATE DETERMINATION OF THESE ADDUCTS ARE NOT AVAILABLE. THE LONG-TERM GOALS OF THIS PROJECT ARE THE DEVELOPMENT OF MONOCLONAL ANTIBODIES SPECIFIC FOR THE MAJOR NUCLEIC ACID ADDUCTS OF THESE DIFUNCTIONAL CARBONYL COMPOUNDS, FOR USE IN ENZYME-LINKED IMMUNOSORBENT ASSAYS AND IN ASSAYS OF SPREAD DNA AND DNA IN NUCLEI. THESE ASSAYS WILL BE DEVELOPED FOR USE IN CLINICAL AND RESEARCH MONITORING OF LEVELS OF THESE ADDUCTS IN HUMAN DNA SAMPLES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.